Rossari Biotech Limited IPO
Rossari Biotech Limited was a mainboard IPO in the Specialty Chemicals sector, offered at ₹423–₹425 per share to raise ₹496 crore. The issue was subscribed 79.37× overall (QIBs 85.26×, NIIs 239.83×, retail 7.23×). It listed on 23 Jul 2020 at ₹669 and closed its first day at ₹742, a listing gain of +74.5% versus the ₹425 issue price. It now trades around ₹399 (-6.1% versus the issue price).
Frequently asked questions
- How many times was the Rossari Biotech Limited IPO subscribed?
- The Rossari Biotech Limited IPO was subscribed 79.37× overall — 85.26× in the QIB category, 239.83× among non-institutional investors, 7.23× in retail.
- What were the Rossari Biotech Limited IPO listing gains?
- Rossari Biotech Limited listed on 23 Jul 2020 at ₹669, closing its first day at ₹742 — a listing gain of +74.5% versus the ₹425 issue price.
- What were the retail allotment odds for the Rossari Biotech Limited IPO?
- Retail was subscribed 7.23×, so a single-lot application had roughly a 13.8% chance of allotment (about 1 in 7), and allotment was finalised on 17 Jul 2020.
- What was the price band and lot size of the Rossari Biotech Limited IPO?
- The price band was ₹423–₹425 per share, with a minimum lot of 35 shares (₹14,875 at the upper band).
- Who were the registrar and lead manager for the Rossari Biotech Limited IPO?
- Link Intime India Private Limited was the registrar, and Axis Capital was the book-running lead manager.